filmov
tv
October 2023 ACIP Meeting - Public comment & RSV Vaccines
![preview_player](https://i.ytimg.com/vi/6it3x-plFeg/sddefault.jpg)
Показать описание
Public comment; VOTES; RSV-Adults: Introduction; GSK safety and immunogenicity in persons 50-59 years of age;Epidemiology of RSV in adults;Work group interpretation and ACIP discussion
This video can also be viewed at
This video can also be viewed at